Stephanie Darmanin
- Immunology top 10%
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
-
- Cancer, Hypoxia, and Metabolism 4
-
- Peptidase Inhibition and Analysis 3
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 3
-
- Chronic Myeloid Leukemia Treatments 2
-
- Eosinophilic Disorders and Syndromes 2
-
- Retinoids in leukemia and cellular processes 2
- Co-authors
- Masanobu KobayashiMasahiro AsakaSamuel C. C. ChiangYenan T. BrycesonJakob TheorellHeinrich SchlumsStephanie M. WoodCyril Fauriat
- Cited by
- ImmunologyCancer ResearchOncology
- Partner nations
- JapanSwedenUnited States
In The Last Decade
Stephanie Darmanin
18 papers receiving 746 citations
Peers
Comparison fields: 5 of 84
- Immunology 266
- Cancer Research 126
- Oncology 214
- Pathology and Forensic Medicine 138
- Hematology 62
Countries citing papers authored by Stephanie Darmanin
This map shows the geographic impact of Stephanie Darmanin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Darmanin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Darmanin more than expected).
Fields of papers citing papers by Stephanie Darmanin
This network shows the impact of papers produced by Stephanie Darmanin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Darmanin. The network helps show where Stephanie Darmanin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephanie Darmanin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 4 | |
| 2 | 2016 | 2 | |
| 3 | 2014 | 19 | |
| 4 | Totarol content and cytotoxicity varies significantly in different types of propolis | 2013 | 4 |
| 5 | 2012 | 5 | |
| 6 | 2012 | 4 | |
| 7 | 2011 | 159 | |
| 8 | 2010 | 72 | |
| 9 | 2010 | 0 | |
| 10 | 2009 | 80 | |
| 11 | 2009 | 76 | |
| 12 | 2009 | 39 | |
| 13 | 2008 | 35 | |
| 14 | 2007 | 60 | |
| 15 | 2007 | 65 | |
| 16 | 2007 | 84 | |
| 17 | 2006 | 11 | |
| 18 | 2005 | 42 | |
| 19 | 2001 | 1 |
About Stephanie Darmanin
Stephanie Darmanin is a scholar working on Immunology, Pathology and Forensic Medicine and Cancer Research, having authored 19 papers that have together received 762 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Mechanisms and Therapy (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), Peptidase Inhibition and Analysis (3 papers), Eosinophilic Disorders and Syndromes (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Immunology (266 citations), Cancer Research (126 citations) and Oncology (214 citations). Stephanie Darmanin has collaborated with scholars based in Japan, Sweden and United States. Frequent co-authors include Masanobu Kobayashi, Masahiro Asaka, Samuel C. C. Chiang, Yenan T. Bryceson, Jakob Theorell, Heinrich Schlums, Stephanie M. Wood, Cyril Fauriat, Sai‐Ching J. Yeung and Christopher Gully. Their work appears in journals such as The Journal of Immunology, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.